1138 related articles for article (PubMed ID: 24112666)
1. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
Madbouly KM; Abbas KS; Hussein AM
Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
[TBL] [Abstract][Full Text] [Related]
2. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.
Leibold T; Shia J; Ruo L; Minsky BD; Akhurst T; Gollub MJ; Ginsberg MS; Larson S; Riedel E; Wong WD; Guillem JG
J Clin Oncol; 2008 May; 26(13):2106-11. PubMed ID: 18362367
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic value of lymph node ratio in survival of patients with stage III rectal cancer].
Zhu XW; Wu CS; Yuan SC
Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):506-9. PubMed ID: 22967468
[TBL] [Abstract][Full Text] [Related]
5. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
[TBL] [Abstract][Full Text] [Related]
6. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
Mariette C; Piessen G; Briez N; Triboulet JP
Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546
[TBL] [Abstract][Full Text] [Related]
7. Less than 12 nodes in the surgical specimen after total mesorectal excision following neoadjuvant chemoradiation: it means more than you think!
de Campos-Lobato LF; Stocchi L; de Sousa JB; Buta M; Lavery IC; Fazio VW; Dietz DW; Kalady MF
Ann Surg Oncol; 2013 Oct; 20(11):3398-406. PubMed ID: 23812804
[TBL] [Abstract][Full Text] [Related]
8. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival.
Rullier A; Laurent C; Capdepont M; Vendrely V; Belleannée G; Bioulac-Sage P; Rullier E
Am J Surg Pathol; 2008 Jan; 32(1):45-50. PubMed ID: 18162769
[TBL] [Abstract][Full Text] [Related]
9. Impact of Total Lymph Node Count on Staging and Survival After Neoadjuvant Chemoradiation Therapy for Rectal Cancer.
Hall MD; Schultheiss TE; Smith DD; Fakih MG; Kim J; Wong JY; Chen YJ
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S580-7. PubMed ID: 25956577
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the concept of lymph node metastases of pancreatic head cancer: number of metastatic lymph nodes and lymph node ratio according to N stage.
Kang MJ; Jang JY; Chang YR; Kwon W; Jung W; Kim SW
Ann Surg Oncol; 2014 May; 21(5):1545-51. PubMed ID: 24419758
[TBL] [Abstract][Full Text] [Related]
11. The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision.
Kim YW; Kim NK; Min BS; Lee KY; Sohn SK; Cho CH
Ann Surg; 2009 Jun; 249(6):965-72. PubMed ID: 19474683
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of lymphadenectomy in patients receiving neoadjuvant radiotherapy for rectal adenocarcinoma.
Le M; Nelson R; Lee W; Mailey B; Duldulao M; Chen YJ; Garcia-Aguilar J; Kim J
Ann Surg Oncol; 2012 Nov; 19(12):3713-8. PubMed ID: 22688661
[TBL] [Abstract][Full Text] [Related]
13. Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement.
Sprenger T; Rothe H; Becker H; Beissbarth T; Homayounfar K; Gauss K; Kitz J; Wolff H; Scheel AH; Ghadimi M; Rödel C; Conradi LC; Liersch T
Am J Surg Pathol; 2013 Aug; 37(8):1283-9. PubMed ID: 23851331
[TBL] [Abstract][Full Text] [Related]
14. The prognostic impact of the number of lymph nodes retrieved after neoadjuvant chemoradiotherapy with mesorectal excision for rectal cancer.
Kim YW; Kim NK; Min BS; Lee KY; Sohn SK; Cho CH; Kim H; Keum KC; Ahn JB
J Surg Oncol; 2009 Jul; 100(1):1-7. PubMed ID: 19418495
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer.
Persiani R; Biondi A; Gambacorta MA; Bertucci Zoccali M; Vecchio FM; Tufo A; Coco C; Valentini V; Doglietto GB; D'Ugo D
Br J Surg; 2014 Jan; 101(2):133-42. PubMed ID: 24375303
[TBL] [Abstract][Full Text] [Related]
16. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
17. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
[TBL] [Abstract][Full Text] [Related]
18. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy.
Morcos B; Baker B; Al Masri M; Haddad H; Hashem S
Eur J Surg Oncol; 2010 Apr; 36(4):345-9. PubMed ID: 20071133
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.
Zhang M; Wang J; Shi W; Chen W; Li W; Shu Y; Liu P; Lu K
Chin Med J (Engl); 2014; 127(10):1874-8. PubMed ID: 24824248
[TBL] [Abstract][Full Text] [Related]
20. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]